Dec 19, 2014 at 15:58 | Source: PTI
The collaboration has been established for an oral controlled release product utilising Panacea's platform of oral drug delivery technology, Panacea Biotec Ltd said in a statement.
Dec 19, 2014 at 15:51 | Source: PTI
According to a statement issued by the drug major, the acquisition of Habitrol brand (an over-the-counter nicotine replacement therapy transdermal patch) from Novartis Consumer Health Inc was done following issuance of the proposed consent order from the US Federal Trade Commission (FTC) on November 26.
Dec 19, 2014 at 15:00 | Source: CNBC-TV18
Rajesh Jain, joint managing director, Panacea Biotec expects the USFDA approval for the collaborated drug by next year to early-2016.
Dec 19, 2014 at 14:42 | Source: Moneycontrol.com
The healthcare firm today said it has closed the acquisition of Habitrol brand from Novartis Consumer Health Inc. following issuance of the proposed consent order from the US Federal Trade Commission (FTC) on November 26, 2014.
Dec 16, 2014 at 16:41 | Source: PTI
The company has launched Valganciclovir tablets, USP in the strength of 450 mg in the US market on December 15, 2014 and the product has been approved by the United States Food and Drug Administration (USFDA), Dr Reddy's Laboratories said in a filing to the BSE today.
Dec 15, 2014 at 21:14 | Source: CNBC-TV18
As a result of its post merger consultation with the US Federal Trade Commission (FTC), the Sun-Ranbaxy combine will most probably have to sell just one drug for the merger to get the green light.
Dec 15, 2014 at 16:57 | Source: Moneycontrol.com
Combat Drugs has informed that a meeting of the Board of Directors of the Company will be held on December 22, 2014, to consider the resignation of the Director.
Dec 15, 2014 at 15:31 | Source: PTI
The company has received regulatory approval to launch its first New Chemical Entity (NCE) Synriam in seven African countries -- Nigeria, Uganda, Senegal, Cameroon, Guinea, Kenya and Ivory Coast, Ranbaxy Laboratories said in a statement.
Dec 15, 2014 at 14:52 | Source: PTI
Drug firm Ranbaxy Laboratories has received regulatory nod to launch its indigenously developed anti-malarial drug Synriam in 7 African nations.
Dec 11, 2014 at 15:08 | Source: Moneycontrol.com
The pharma major said its US subsidiary, Lupin Pharmaceuticals Inc has launched the authorised generic for GD Searle LLCs (a subsidiary of Pfizer Inc.) Celebrex capsules 50 mg, 100 mg, 200 mg and 400 mg strengths.